Crow Point Partners »

Alnylam Pharmaceuticals shares owned by Crow Point Partners

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Crow Point Partners from 13F filings

Historical chart of Crow Point Partners investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Crow Point Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Crow Point Partners

Quarter filed Position value Share count Share price at filing
2019-12-31 $206k 1.8k 114.44
2019-03-31 $205k 2.2k 93.61

More positions owned by Crow Point Partners

iShares S&P MidCap 400 Index (IJH)
Spdr Bloomberg Barclays High Yield Bond Etf etf (JNK)
iShares S&P Natl AMTFr Mncpl Bd (MUB)
iShares Barclays 20+ Yr Treas.Bond (TLT)
iShares Lehman Aggregate Bond (AGG)
iShares MSCI Netherlands Investable (EWN)
Vaneck Vectors J.p. Morgan Em Local Currency Bond Etf etf (EMLC)
Ishares Inc emrg mrk lc bd (LEMB)
Royce Value Trust (RVT)
Spdr S&p 500 Etf (SPY)
Ishares Tr core msci pac (IPAC)
Tesla Motors (TSLA)
iShares MSCI Germany Index Fund (EWG)
iShares Russell 2000 Growth Index (IWO)
Eaton Vance Limited Duration Income Fund (EVV)

View all positions for Crow Point Partners

Top funds holding Alnylam Pharmaceuticals

Vanguard Group
BlackRock
Wellington Management Company
Baillie Gifford & Co
Dodge & Cox
T. Rowe Price Associates
Norges Bank Investment Management
Jpmorgan Chase & Co
Susquehanna International
venBio Select Advisor
Legal & General Group
Bellevue Group
Bank of New York Mellon
Ubs Global Asset Management Americas
Amundi

View all funds holding Alnylam Pharmaceuticals